Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients
by Pautex, S., Bianchi, F., Daali, Y., Augsburger, M., de Saussure, C., Wampfler, J., Curtin, F., Desmeules, J. and Broers, B. (2022). Front. Aging Neurosci. 14:957665. doi: 10.3389/fnagi.2022.957665
An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Geneva.”
The original article has been updated.
Keywords: cannabinoids, dementia, symptoms relief, long-term care, medical cannabis
Citation: Frontiers Production Office (2023) Erratum: Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients. Front. Aging Neurosci. 15:1176468. doi: 10.3389/fnagi.2023.1176468
Received: 28 February 2023; Accepted: 28 February 2023;
Published: 09 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org